J. Keating

Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification.

A. Peaston, W. Weiss, P. Armati, 2004, Proceedings of the National Academy of Sciences of the United States of America.

ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.

W. London, M. Hogarty, A. Buxton, 2008, Cancer research.

Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation

H. Ding, Ella L. Kim, H. Cui, 2013, Oncogene.

Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects

F. Stossi, B. Katzenellenbogen, A. Biankin, 2010, Oncogene.

Targeting the Inhibitor of Apoptosis Proteins as a Novel Therapeutic Strategy in Medulloblastoma

A. Hallahan, W. J. Ingram, M. Haber, 2012, Molecular Cancer Therapeutics.

A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivo.

S. Kesari, L. Zawel, A. Kung, 2011, Neuro-oncology.